We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Huntsman Cancer Institute Joins National Clinical Trial Targeting AML

News   Mar 19, 2018 | Original story from the Huntsman Cancer Institute (HCI)

 
Huntsman Cancer Institute Joins National Clinical Trial Targeting AML

These are the HCI physicians from left to right: Paul Shami, M.D., Tibor Kovacsovics, M.D. and Michael Deininger, M.D., Ph.D. Credit: Jonathan Martinez, Huntsman Cancer Institute

 
 
 

RELATED ARTICLES

Psoriasis Drug Target Holds Potential for Bone Cancer

News

Researchers have discovered a potential therapeutic target for osteosarcoma – one which is already used to treat psoriasis.

READ MORE

More Than 100,000 Cancer Cases Could Stem From Contaminants in Tap Water, Study Suggests

News

A toxic cocktail of chemical pollutants in U.S. drinking water could result in more than 100,000 cancer cases, according to a peer-reviewed study from Environmental Working Group.

READ MORE

Team Redesign Molecules To Fight Malaria

News

Redesigning molecules originally developed to treat the skin disease psoriasis could lead to an effective new drug against malaria, according to new study findings.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE